| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.642 | 12.542 | 11.660 | 16.890 | 10.463 | 31.303 | 36.947 | 58.885 | 51.758 |
| Total Income - EUR | - | 10.642 | 12.542 | 11.843 | 16.890 | 10.472 | 31.304 | 37.022 | 58.891 | 52.303 |
| Total Expenses - EUR | - | 3.109 | 3.329 | 616 | 12.525 | 15.171 | 15.350 | 16.314 | 6.342 | 8.020 |
| Gross Profit/Loss - EUR | - | 7.533 | 9.213 | 11.227 | 4.365 | -4.698 | 15.954 | 20.708 | 52.549 | 44.284 |
| Net Profit/Loss - EUR | - | 7.213 | 8.837 | 10.875 | 3.857 | -5.036 | 15.015 | 19.588 | 43.641 | 36.661 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hema Med Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 47 | 0 | 0 | 42.836 | 28.753 | 15.139 | 2.169 | 0 | 0 |
| Current Assets | - | 10.528 | 16.028 | 11.127 | 6.167 | 6.534 | 5.708 | 22.147 | 52.563 | 40.900 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.747 | 958 | 2.989 | 4.017 | 2.835 | 3.093 | 6.159 | 9.887 | 23.581 |
| Cash | - | 6.781 | 15.071 | 8.138 | 2.150 | 3.698 | 2.615 | 15.987 | 42.677 | 17.319 |
| Shareholders Funds | - | 7.258 | 15.972 | 10.918 | 3.900 | -1.210 | 13.832 | 19.628 | 43.681 | 36.701 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.317 | 56 | 209 | 45.104 | 36.497 | 7.016 | 4.688 | 8.882 | 4.199 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hema Med Consulting Srl